Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.385 USD | -3.84% | -15.52% | -61.33% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.33% | 470M | |
+61.12% | 62.59B | |
-2.20% | 41.18B | |
+44.70% | 40.29B | |
-8.29% | 27.9B | |
+12.66% | 26.21B | |
-21.82% | 19.09B | |
+5.50% | 13.08B | |
+24.94% | 12.26B | |
+28.02% | 12.05B |
- Stock Market
- Equities
- VERV Stock
- News Verve Therapeutics, Inc.
- Credit Suisse Lowers Verve Therapeutics' Price Target to $32 From $37, Maintains Neutral Rating